Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Call us at 1-800-227-2345
Available any time of day or night
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
After a woman is diagnosed with uterine sarcoma, doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes the amount of cancer spread in the body and helps determine how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.
Uterine sarcoma stages range from stage I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And sometimes, a stage might be divided further using letters. An earlier letter means a lower stage. Although each person’s cancer experience is unique, cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
The systems used to stage uterine sarcoma, the FIGO (International Federation of Gynecology and Obstetrics) system and the (AJCC) American Joint Committee on Cancer TNM staging system are basically the same.
They both stage (classify) this cancer based on 3 factors:
Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced. Once a person’s T, N, and M categories have been determined, this information is combined in a process called stage grouping to assign an overall stage.
The staging system in the table below uses the pathologic stage (also called the surgical stage). It is determined by examining tissue removed during an operation. Sometimes, if surgery is not possible, the cancer will be given a clinical stage instead. This is based on the results of a physical exam, biopsy, and imaging tests done without surgery. For more information see Cancer Staging.
The system described below is the most recent AJCC system, effective January 2018. It is only for staging leiomyosarcoma and endometrial stromal sarcoma.
Uterine sarcoma staging can be complex, so ask your doctor to explain it to you in a way you understand.
Stage |
Stage grouping |
FIGO Stage |
Stage description* |
I |
T1 N0 M0 |
I |
The cancer is growing in the uterus, but has not started growing outside the uterus. It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
IA |
T1a N0 M0 |
IA |
The cancer is only in the uterus and is no larger than 5 cm across (about 2 inches) (T1a). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
IB |
T1b N0 M0 |
IB |
The cancer is only in the uterus and is larger than 5 cm across (about 2 inches). (T1b). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
II
|
T2 N0 M0 |
II |
The cancer is growing outside the uterus but is not growing outside of the pelvis (T2). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
|
IIIA |
T3a N0 M0 |
IIIA |
The cancer is growing into tissues of the abdomen in one place only (T3a). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
|
IIIB |
T3b N0 M0 |
IIIB |
The cancer is growing into tissues of the abdomen in 2 or more places (T3b). It has not spread to nearby lymph nodes (N0) or to distant sites (M0).
|
IIIC |
T1-T3 N1 M0 |
IIIC |
The cancer is growing in the body of the uterus and it might have spread into tissues of the abdomen, but is not growing into the bladder or rectum (T1 to T3). The cancer has spread to nearby lymph nodes (N1), but not to distant sites (M0). |
IVA |
T4 Any N M0 |
IVA |
The cancer has spread to the rectum or urinary bladder (T4). It might or might not have spread to nearby lymph nodes (Any N) but has not spread to distant sites (M0). |
IVB |
Any T Any N M1 |
IVB |
The cancer has spread to distant sites such as the lungs, bones, or liver (M1). The cancer in the uterus can be any size and may or may not have grown into tissues in the pelvis and/or abdomen (including the bladder or rectum) (any T) and it might or might not have spread to nearby lymph nodes (Any N). |
* The following additional categories are not listed on the table above:
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as editors and translators with extensive experience in medical writing.
American Joint Committee on Cancer. Corpus Uteri. In: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010: 403-409.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Uterine Neoplasms, Version 1.2022 – November 4, 2021. Accessed at https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf on June 7, 2022.
Last Revised: September 20, 2022
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.